SSKN News and Press, Strata Skin Sciences Inc. From 05/19/23

HORSHAM, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced Joel L. Cohen, MD (FAAD, FACMS), Director...

2023-05-15 20:45:05 ET STRATA Skin Sciences, Inc. (SSKN) Q1 2023 Results Conference Call May 15, 2023 04:30 PM ET Company Participants Bob Moccia - Chief Executive Officer Chris Lesovitz - Chief Financial Officer Conference Call Participants Jeffrey Cohen...

2023-05-15 16:06:09 ET STRATA Skin Sciences press release ( NASDAQ: SSKN ): Q1 GAAP EPS of -$0.08 misses by $0.01 . Revenue of $7.6M (+8.6% Y/Y) beats by $0.1M . STRATA continues to expect full year 2023 revenue to range from $38.0 million to $40.0 million vs $...

Achieved revenue of $7.6 million for the first quarter 2023 Company to host conference call and webcast today, May 15, 2023, at 4:30 PM ET HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developi...

STRATA expects to receive regulatory approval in India during December 2023 India has the highest prevalence of vitiligo in the world, at about 8.8% 1 HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedic...

HORSHAM, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will participate in the Inaug...

HORSHAM, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its first quarte...

STRATA Skin Sciences (NASDAQ: SSKN) is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC(R) excimer lasers, V...

2023-04-12 08:18:57 ET Strata Skin Sciences ( NASDAQ: SSKN ) expects revenue in the range of $7.3M - $7.8M for the first quarter of 2023, compared to analysts estimate of $7.9M. This would be the medical technology company's strongest first-quarter results since the first ...

Preliminary revenue to be within the range of $7.3 - $7.8 million and expected to be the strongest first-quarter results since first quarter of 2016 Company exceeds plan with 44 TheraClear ® X placements in the first quarter HORSHAM, Pa., April 12, 2023 (GLOBE NEWSWIRE) -- STRA...